Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
145,100
+6,100 (4.39%)
Feb 9, 2026, 9:18 AM KST

Mezzion Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,220,584924,3691,153,908347,6461,932,2351,563,338
Market Cap Growth
364.11%-19.89%231.92%-82.01%23.60%-6.13%
Enterprise Value
4,203,017891,1051,093,258314,5211,903,2611,542,499
Last Close Price
139000.0030850.0039000.0013000.0072366.6758600.00
PS Ratio
544.63107.3436.3811.3172.4954.60
PB Ratio
113.0220.0718.7813.2530.7727.52
P/TBV Ratio
118.1420.8019.2914.1231.5928.33
EV/Sales Ratio
-103.4834.4710.2471.4153.87
EV/FCF Ratio
-372.48-----
Debt / Equity Ratio
0.290.040.040.040.070.09
Asset Turnover
0.100.100.430.450.330.43
Inventory Turnover
1.151.203.823.012.443.26
Quick Ratio
0.601.122.121.352.723.35
Current Ratio
0.881.572.511.763.473.91
Return on Equity (ROE)
-48.05%-36.23%-29.03%-81.54%-22.75%-27.85%
Return on Assets (ROA)
-12.10%-10.76%-12.39%-21.14%-13.16%-7.00%
Return on Invested Capital (ROIC)
-93.93%-116.73%-8454.47%-321.28%-103.59%-83.31%
Return on Capital Employed (ROCE)
-40.80%-30.20%-23.20%-83.50%-25.70%-12.50%
Earnings Yield
-0.52%-2.11%-1.10%-10.44%-0.70%-0.89%
FCF Yield
-0.27%-2.06%-1.00%-3.69%-0.80%-0.52%
Buyback Yield / Dilution
-1.06%-5.62%-5.63%-0.17%-2.63%-0.11%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.